OQROGet OQRO Pro
Insider trade

Johnson & Johnson (JNJ)CEO sold ~$10.8M

Joaquin Duato, CEO at Johnson & Johnson, sold ~$10.8M of Johnson & Johnson shares.

~$10.8M
Approx. value · 49K sh @ $221.48
31K
Holds after · shares reported
Traded
Jan 26, 2026
Filed
Jan 28, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 5, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  2. Nov 13, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  3. Nov 20, 2025CongressDisclosed partial sale of JNJ — reported range $15,001 - $50,000
  4. Nov 25, 2025Insider10% owner sold ~$160K of JNJ shares in the open market
  5. Nov 26, 2025Insider · 2 peopleInsiders: 1 purchase (~$258K), 2 sales (~$127K)
  6. Dec 9, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  7. Dec 10, 2025Federal contract · $8K obligatedDepartment of Defense awarded Johnson & Johnson: $7.7K obligated to date
  8. Dec 18, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  9. Jan 21, 2026Company filing · Form 8-K · ResultsReported its results
  10. Jan 23, 2026CongressDisclosed partial sale of JNJ — reported range $15,001 - $50,000
  11. Jan 26, 2026 · this disclosureInsiderCEO sold ~$10.8M of JNJ shares in the open market

What came next

  1. Jan 26, 2026InsiderCEO sold ~$11.3M of JNJ shares in the open market
  2. Feb 5, 20265% stakeThe Vanguard Group reported a passive stake (13G) of 10.1%
  3. Feb 11, 2026Federal contract · $280K obligatedDepartment of Defense awarded Johnson & Johnson: $280K obligated to date
  4. Feb 13, 2026Insider · 1 personInsiders: 2 sales (~$10.1M)
  5. Feb 17, 2026Insider · 4 peopleInsiders: 9 sales (~$41.4M)
  6. Feb 18, 2026Insider · 1 personInsiders: 2 sales (~$5.5M)
  7. Feb 19, 2026Federal contract · $155K obligatedDepartment of Defense awarded Johnson & Johnson: $155K obligated to date
  8. Feb 20, 2026InsiderChair sold ~$325K of JNJ shares in the open market
  9. Feb 23, 2026Federal contract · $371K obligatedDepartment of Defense awarded Johnson & Johnson: $371K obligated to date
  10. Feb 26, 2026Federal contract · $272K obligatedDepartment of Defense awarded Johnson & Johnson: $272K obligated to date
  11. Feb 27, 2026InsiderOfficer sold ~$1.01M of JNJ shares in the open market
  12. Mar 4, 2026Federal contract · $205K obligatedDepartment of Defense awarded Johnson & Johnson: $205K obligated to date
  13. Mar 10, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  14. Mar 19, 2026Congress · 2 peopleMembers of Congress: 3 sales
  15. Mar 20, 2026Federal contract · $20K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $20K obligated to date
  16. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  17. Mar 26, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  18. Apr 14, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  19. Apr 20, 2026FDARecall: Automated Impella Controller (AIC); Product Code: 0042-0000-US;
  20. May 1, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 15 insider filings (SEC Form 4 or Form 144), 8 Congress trade reports, 167 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Joaquin Duato, CEO and Chairman of the Board

The full history of Joaquin Duato, CEO and Chairman of the Board is on the profile page.

How this filing works

Other disclosures at Johnson & Johnson

Everything OQRO holds on this company is on its JNJ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data